Friday, June 5, 2026

KOSPI Soars 26.2% in February: What This Means for Asian Investors

South Korea's KOSPI index surged 26.2% in February while U.S. stocks declined, prompting a trend of capital outflow from the U.S. market.

Kim Sae Ron, Former Child Star, Passes Away at 24; No Foul Play Suspected

The tragic death of actress Kim Sae Ron at just 24 has shocked fans and colleagues, prompting an outpouring of grief online.

Lotte Biologics at DCAT Week 2026: Unveiling Strategic Collaborations in Global CDMO

Lotte Biologics will attend DCAT Week in New York to pursue global CDMO partnerships and showcase its production capabilities.

Tag: Lurasidone

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive Treatment for Major Depression

Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.